Schonfeld Strategic Advisors LLC Denali Therapeutics Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 163,074 shares of DNLI stock, worth $4.29 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
163,074Holding current value
$4.29 Million% of portfolio
0.03%Shares
4 transactions
Others Institutions Holding DNLI
# of Institutions
217Shares Held
115MCall Options Held
127KPut Options Held
38.3K-
Baillie Gifford & CO13.8MShares$362 Million0.25% of portfolio
-
Black Rock Inc. New York, NY13.2MShares$346 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$297 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA9.82MShares$258 Million0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.13MShares$187 Million0.04% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $3.53B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...